(Q81919301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

3

Wim Jiskoot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

5

Wim E Hennink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Carmen Arigita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Thomas Luijkx

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Martien Poelen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Daan J A Crommelin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Peter van der Ley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Cecile van Els

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Gideon F A Kersten

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

5091-5098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Development of vaccines against meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Taking toll: lipid A mimetics as adjuvants and immunomodulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

A simplification of the protein assay method of Lowry et al. which is more generally applicable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Towards the rational design of Th1 adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Recent developments in adjuvants for vaccines against infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Neisseria meningitidis serogroup B: laboratory correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Expression ofNeisseria meningitidisclass 1 porin as a fusion protein inEscherichia colli: the influence of liposomes and adjuvants on the production of a bactericidal immune reesponse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Monophosphoryl lipid A activates both human dendritic cells and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

TH1-TH2: a procrustean paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.06.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993990%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference